The U.S. Food and Drug Administration (FDA) recently approved the use of Teplizumab, a new, immunotherapy drug that has been shown to delay the onset of type 1 diabetes by at least two years. The drug ...

The University of California, San Francisco (UCSF) has signed an alliance with international pharmaceutical company Sanofi (EURONEXT: SAN and NYSE: SNY) to share expertise in diabetes research and ...

A UCSF/San Francisco General Hospital project that used a novel communication tool to improve health outcomes among diabetes patients was honored recently with a quality leadership award from the ...

INTERVIEW, PHOTO AND AUDIO/VIDEO OPPORTUNITIES: UCSF faculty pharmacists, Friday: national experts in diabetes research and care; Saturday: UCSF diabetes physicians and patients. Lab experiments for ...

UCSF raising awareness about type 2 diabetes in children Asst. Professor of Pediatrics UCSF Dr. Shylaja Srinivasan, discusses the importance of bringing awareness and addressing stigmas related to ...

UC Berkeley’s College of Computing, Data Science and Society, or CDSS, launched the Agile Metabolic Health project earlier this month in partnership with UCSF to improve the treatment of diabetes and ...

Virta Health, a San Francisco-based startup that brands itself as an online clinic to “safely and sustainably reverse Type 2 diabetes,” released one-year results of a study into its treatment model ...